Repligen Corporation (RGEN)
NASDAQ: RGEN · IEX Real-Time Price · USD
160.14
+1.77 (1.12%)
May 2, 2024, 12:22 PM EDT - Market open
Repligen Employees
Repligen had 1,783 employees on December 31, 2023. The number of employees decreased by 242 or -11.95% compared to the previous year.
Employees
1,783
Change (1Y)
-242
Growth (1Y)
-11.95%
Revenue / Employee
$340,690
Profits / Employee
$8,324
Market Cap
8.94B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,783 | -242 | -11.95% |
Dec 31, 2022 | 2,025 | 173 | 9.34% |
Dec 31, 2021 | 1,852 | 724 | 64.18% |
Dec 31, 2020 | 1,128 | 367 | 48.23% |
Dec 31, 2019 | 761 | 213 | 38.87% |
Dec 31, 2018 | 548 | 72 | 15.13% |
Dec 31, 2017 | 476 | 240 | 101.69% |
Dec 31, 2016 | 236 | 68 | 40.48% |
Dec 31, 2015 | 168 | 32 | 23.53% |
Dec 31, 2014 | 136 | 20 | 17.24% |
Dec 31, 2013 | 116 | -4 | -3.33% |
Dec 31, 2012 | 120 | -17 | -12.41% |
Dec 31, 2011 | 137 | 69 | 101.47% |
May 6, 2010 | 68 | -1 | -1.45% |
May 31, 2009 | 69 | 13 | 23.21% |
May 27, 2008 | 56 | 11 | 24.44% |
Jun 30, 2007 | 45 | 2 | 4.65% |
Jun 6, 2006 | 43 | 6 | 16.22% |
Jun 7, 2005 | 37 | -3 | -7.50% |
Jun 7, 2004 | 40 | -4 | -9.09% |
May 15, 2003 | 44 | 5 | 12.82% |
May 15, 2002 | 39 | -1 | -2.50% |
May 15, 2001 | 40 | 13 | 48.15% |
May 15, 2000 | 27 | 3 | 12.50% |
May 15, 1999 | 24 | 0 | - |
May 29, 1998 | 24 | 4 | 20.00% |
May 15, 1997 | 20 | 5 | 33.33% |
Jun 14, 1996 | 15 | -89 | -85.58% |
Mar 31, 1995 | 104 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Tenet Healthcare | 106,500 |
Encompass Health | 37,761 |
Henry Schein | 25,000 |
Chemed | 15,087 |
Teleflex | 14,500 |
AptarGroup | 13,800 |
Qiagen | 5,967 |
Stevanato Group | 5,634 |
RGEN News
- 1 day ago - Repligen Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 15 days ago - Repligen to Report First Quarter 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Repligen Appoints Maggie A. Pax to Board of Directors - GlobeNewsWire
- 2 months ago - Repligen Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 3 months ago - Repligen to Report Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 4 months ago - Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 months ago - Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription Agreements - GlobeNewsWire
- 6 months ago - UPDATE – Repligen Announces Publication of the Company's 2022 Sustainability Report - GlobeNewsWire